ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Patients Win When Support Is Personalized: New Study From Atlantis Healthcare Shows Treatment Persistence and Adherence Improved by 38%
March 08, 2021Leading patient outcomes journal Patient Preference and Adherence has published a study that demonstrates significant improvement in treatment behaviors among patients with neovascular age-related macular degeneration (nAMD) who received personalized ... -
EyePoint Announces First Patient Dosed in Trial of EYP-1901 for Wet AMD
February 03, 2021EyePoint Pharmaceuticals announced that the first patient has been dosed in the Phase 1 clinical trial of EYP-1901 as a potential twice-yearly sustained delivery anti-VEGF treatment targeting wet age-related macular degeneration (wet AMD).
Pharma Sources Insight January 2025
